Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China flag China · Delayed Price · Currency is CNY
30.85
+0.19 (0.62%)
At close: Sep 16, 2026

Bright Eye Hospital Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
13.62-60.92-101.86267.9120.5793.89
Depreciation & Amortization
335.61329.36315.75273.82214.82177.71
Other Amortization
93.6693.9583.6468.8951.9942.89
Loss (Gain) From Sale of Assets
0.39-00.93-0.06-0.56-0.93
Asset Writedown & Restructuring Costs
8.88.7960.472.128.62
Loss (Gain) From Sale of Investments
8.8110.173.51-78.29-12.6-9.47
Provision & Write-off of Bad Debts
1.341.34-0.223.371.59-
Other Operating Activities
90.6494.898.1888.5760.452.47
Change in Accounts Receivable
-0.26-4.244.04-23.18-13.26-5.11
Change in Inventory
-29.87-57.142.28-45.68-18.95-12.18
Change in Accounts Payable
106.74124.31-24.3263.9718.0913.41
Change in Other Net Operating Assets
----3.24-1.63
Operating Cash Flow
632.49544.86382.43614.46319.3359.42
Operating Cash Flow Growth
80.58%42.47%-37.76%92.44%-11.16%57.98%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-257.55-226.41-542.86-626.87-327.99-254.8
Sale of Property, Plant & Equipment
4.514.841.450.221.021.76
Cash Acquisitions
-91.85-25.05-588.53--168.7
Investment in Securities
-135.69-202.13-8.63-29.24-274.91-7.6
Other Investing Activities
1.441.561.66-1.02--
Investing Cash Flow
-479.15-447.19-553.38-568.38-601.88-429.47

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-198.5550.13282.8202.5110
Total Debt Issued
261.44198.5550.13282.8202.5110
Short-Term Debt Repaid
------0.58
Long-Term Debt Repaid
--415.88-579.31-391.52-259.13-149.15
Lease Payments
-216.36-216.36-225.21-249.84-145.63-130.99
Total Debt Repaid
-403.98-415.88-579.31-391.52-259.13-149.73
Net Debt Issued (Repaid)
-142.54-217.38-29.18-108.72-56.63-39.73
Issuance of Common Stock
----1,152-
Repurchase of Common Stock
----29.98--
Common Dividends Paid
-18.79-17.75-77.97-27.63-9.04-4.55
Other Financing Activities
-18.96-4.27-47.62--47.94-
Financing Cash Flow
-180.28-239.4-154.78-166.331,038-44.28

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.130.020.1-0.41-0.29-0
Net Cash Flow
-27.07-141.72-325.63-120.65755.46-114.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
374.93318.45-160.43-12.41-8.68104.62
Free Cash Flow Growth
273.37%----29.30%
Free Cash Flow Margin
12.75%11.38%-5.99%-0.46%-0.50%6.12%
Free Cash Flow Per Share
2.502.14-1.07-0.08-0.070.94
Levered Free Cash Flow
289.82208.65-172.7778.631.666.15
Unlevered Free Cash Flow
301.9220.73-162.16125.2937.5896.43
Free Cash Flow After Leases
158.57102.09-385.64-262.25-154.32-26.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
89.2983.55139.5496.4158.0865.41
Change in Working Capital
79.6167.36-23.5-10.23-19.03-5.76